Asher Biotherapeutics IPO

Asher Biotherapeutics, also known as Asher Bio, is a biotechnology company developing immunotherapies intended for cancer, autoimmune disorders, and infectious diseases. Asher Biotherapeutics was founded in 2019 by Ivana Djuretic and Andy Yeungand and is headquartered in San Francisco, CA. The company is committed to creating new treatment paradigms by using its proprietary cis-targeting platform to engineer therapies that selectively engage immune cells.

Register for Details

For more details on financing and valuation for Asher Biotherapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Asher Biotherapeutics

Forge green plus iconForge green minus icon

What is Asher Biotherapeutics's IPO price?

The IPO price for Asher Biotherapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Asher Biotherapeutics?

Asher Biotherapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Asher Biotherapeutics shares pre-IPO?

If you own Asher Biotherapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Asher Biotherapeutics a publicly traded company?

Asher Biotherapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Asher Biotherapeutics's funding to date?

Asher Biotherapeutics has raised $221.65MM to date.
Forge green plus iconForge green minus icon

When was Asher Biotherapeutics founded?

Asher Biotherapeutics was founded in 2019.

Who are Asher Biotherapeutics's major investors?

Wellington Management
Y Combinator
Emles Venture Partners
Ra Capital Management
Bristol Myers Squibb
Marshall Wace
Janus Henderson Investors
The Invus Group
Logos Capital
Third Rock Ventures
Boxer Capital
Alexandria Venture Investments
GoAhead Ventures
Mission BioCapital
MBC BioLabs

Asher Biotherapeutics funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation

Series C

$55MM raised $XXX.XX $XXX.XX

Series B

$108MM raised $XXX.XX $XXX.XX

Series A

$55MM raised $XXX.XX $XXX.XX

Series Seed-1, Seed-2 and Seed-3

$3.65MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jun 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.